Leveraging a novel protein tagging strategy offers new route to cancer treatment
In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...
Medindia8h
Vitamin E Succinate Enhances Cancer Immunotherapy and Slows Tumor Growth
Vitamin E succinate has been found to inhibit tumor growth and enhance the effectiveness of immunotherapy by targeting ...
Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects
High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...
News Medical on MSN1d
Study identifies vitamin E succinate as key to tumor growth control
High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...
technologynetworks1d
Vitamin E Succinate Helps Control Tumor Growth and Enhance Immunotherapy
Researchers at the University of Chicago Medicine identified vitamin E succinate (VES) as an effective agent in suppressing ...
Nature16d
Signs of damage that drive protein degradation
When encountering cellular stress, E3 ligases must deal with proteins that have been damaged in many different ways. For example, misfolding can expose multiple hydrophobic regions in the same ...
Medindia18h
MYCN and MDM2: A Transformative Strategy in Cancer Therapy
Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.
Promising Clinical Developments and Strategic Collaborations Justify Buy Rating for Nurix Therapeutics
Nurix Therapeutics (NRIX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeet ...
J.P. Morgan Keeps Their Buy Rating on Nurix Therapeutics (NRIX)
J.P. Morgan analyst Eric Joseph maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $30.00.